Bayer has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Medrad Centargo CT Injection System.
The system is a multipatient injector that integrates with Bayer’s portfolio of products, especially in high-volume CT suites. It is designed to minimize preparation time to under two minutes, streamlines data entry, and features a piston-based technology that allows for features such as dual flow to deliver contrast and saline at the same time, the company said.
By integrating with Bayer’s portfolio of imaging and workflow solutions, the company added that healthcare providers can optimize contrast usage and enable connectivity to the modality worklist and scanner.
Sunnybrook Health Sciences Centre in Toronto, Canada was the first hospital in North America to install and integrate Bayer’s Medrad Centargo CT Injection System in both acute care and outpatient settings.
